US Patent No. 8,945,928

Mutations in the LNK gene in patients with myeloproliferative neoplasms and other hematolymphoid malignancies
Mar 04, 2015

An unspecified party has been awarded US Patent No. 8,945,928, "Mutations in the LNK gene in patients with myeloproliferative neoplasms and other hematolymphoid malignancies."

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.

Oct
25
Sponsored by
Roche

This webinar will detail a comprehensive strategy that a lab has put in place to evaluate  NGS oncology assays for genomic tumor profiling of plasma and tissue samples.